Kathryn Greven to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Kathryn Greven has written about Neoplasm Recurrence, Local.
Connection Strength
0.583
-
Garg S, Kilburn JM, Lucas JT, Randolph D, Urbanic JJ, Hinson WH, Kearns WT, Porosnicu M, Greven K. Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis. Head Neck. 2016 04; 38 Suppl 1:E961-9.
Score: 0.376
-
Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011 Feb; 21(2):419-23.
Score: 0.069
-
Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. Cancer. 2007 Apr 15; 109(8):1506-12.
Score: 0.053
-
Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):168-73.
Score: 0.043
-
Greven KM. Positron-emission tomography for head and neck cancer. Semin Radiat Oncol. 2004 Apr; 14(2):121-9.
Score: 0.043